Mazzarello S - Search Results

1

Optimal primary febrile neutropenia prophylaxis for patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer: a systematic review.

Fernandes R, Mazzarello S, Stober C, Vandermeer L, Dudani S, Ibrahim MF, Majeed H, Perdrizet K, Shorr R, Hutton B, Fergusson D, Clemons M. Fernandes R, et al. Among authors: mazzarello s. Breast Cancer Res Treat. 2017 Jan;161(1):1-10. doi: 10.1007/s10549-016-4028-0. Epub 2016 Oct 25. Breast Cancer Res Treat. 2017. PMID: 27783280 Review.

2

A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events.

Addison CL, Bouganim N, Hilton J, Vandermeer L, Dent S, Amir E, Hopkins S, Kuchuk I, Segal R, Song X, Gertler S, Mazzarello S, Dranitsaris G, Ooi D, Pond G, Clemons M. Addison CL, et al. Among authors: mazzarello s. Breast Cancer Res Treat. 2014 Apr;144(3):615-24. doi: 10.1007/s10549-014-2906-x. Epub 2014 Mar 18. Breast Cancer Res Treat. 2014. PMID: 24638849 Free PMC article. Clinical Trial.

3

Optimisation of steroid prophylaxis schedules in breast cancer patients receiving docetaxel chemotherapy-a survey of health care providers and patients.

Jacobs C, Hutton B, Mazzarello S, Smith S, Joy A, Amir E, Ibrahim MF, Gregario N, Daigle K, Eggert L, Clemons M. Jacobs C, et al. Among authors: mazzarello s. Support Care Cancer. 2015 Nov;23(11):3269-75. doi: 10.1007/s00520-015-2731-8. Epub 2015 May 3. Support Care Cancer. 2015. PMID: 25933700

4

Management of urogenital atrophy in breast cancer patients: a systematic review of available evidence from randomized trials.

Mazzarello S, Hutton B, Ibrahim MFK, Jacobs C, Shorr R, Smith S, Ng T, Clemons M. Mazzarello S, et al. Breast Cancer Res Treat. 2015 Jul;152(1):1-8. doi: 10.1007/s10549-015-3434-z. Epub 2015 May 24. Breast Cancer Res Treat. 2015. PMID: 26003182 Review.

5

Treatment of taxane acute pain syndrome (TAPS) in cancer patients receiving taxane-based chemotherapy-a systematic review.

Fernandes R, Mazzarello S, Majeed H, Smith S, Shorr R, Hutton B, Ibrahim MF, Jacobs C, Ong M, Clemons M. Fernandes R, et al. Among authors: mazzarello s. Support Care Cancer. 2016 Apr;24(4):1583-94. doi: 10.1007/s00520-015-2941-0. Epub 2015 Sep 19. Support Care Cancer. 2016. PMID: 26386706 Review.

6

Identifying an optimal antiemetic regimen for patients receiving anthracycline and cyclophosphamide-based chemotherapy for breast cancer--an inspection of the evidence base informing clinical decision-making.

Hutton B, Clemons M, Mazzarello S, Kuchuk I, Skidmore B, Ng T. Hutton B, et al. Among authors: mazzarello s. Cancer Treat Rev. 2015 Dec;41(10):951-9. doi: 10.1016/j.ctrv.2015.09.007. Epub 2015 Sep 30. Cancer Treat Rev. 2015. PMID: 26442474 Review.

7

Choice of study endpoint significantly impacts the results of breast cancer trials evaluating chemotherapy-induced nausea and vomiting.

Ng T, Mazzarello S, Wang Z, Hutton B, Dranitsaris G, Vandermeer L, Smith S, Clemons M. Ng T, et al. Among authors: mazzarello s. Breast Cancer Res Treat. 2016 Jan;155(2):337-44. doi: 10.1007/s10549-015-3669-8. Epub 2016 Jan 5. Breast Cancer Res Treat. 2016. PMID: 26732944 Clinical Trial.

8

Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer-a systematic review.

Fernandes R, Mazzarello S, Hutton B, Shorr R, Majeed H, Ibrahim MF, Jacobs C, Ong M, Clemons M. Fernandes R, et al. Among authors: mazzarello s. Support Care Cancer. 2016 Aug;24(8):3633-50. doi: 10.1007/s00520-016-3256-5. Epub 2016 May 5. Support Care Cancer. 2016. PMID: 27146496 Review.

9

Optimal Management of Leptomeningeal Carcinomatosis in Breast Cancer Patients-A Systematic Review.

Dudani S, Mazzarello S, Hilton J, Hutton B, Vandermeer L, Fernandes R, Ibrahim MF, Smith S, Majeed H, Al-Baimani K, Caudrelier JM, Shorr R, Clemons M. Dudani S, et al. Among authors: mazzarello s. Clin Breast Cancer. 2016 Dec;16(6):456-470. doi: 10.1016/j.clbc.2016.07.014. Epub 2016 Jul 28. Clin Breast Cancer. 2016. PMID: 27553811 Review.

10

A Systematic Review of the Incidence and Risk Factors for Taxane Acute Pain Syndrome in Patients Receiving Taxane-Based Chemotherapy for Prostate Cancer.

Fernandes R, Mazzarello S, Hutton B, Shorr R, Ibrahim MFK, Jacobs C, Ong M, Clemons M. Fernandes R, et al. Among authors: mazzarello s. Clin Genitourin Cancer. 2017 Feb;15(1):1-6. doi: 10.1016/j.clgc.2016.07.018. Epub 2016 Jul 28. Clin Genitourin Cancer. 2017. PMID: 27554586 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

70 results

Search Page